Inactive Instrument

Other languages Stereotaxis Inc Nasdaq

Equities

US85916J4094

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

Stereotaxis, Inc. Announces Regulatory Submissions of the MAGiC Ablation Catheter in Europe and the United States	03-04
Stereotaxis, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	03-04
Stereotaxis, Inc. Provides Revenue Guidance for the First Quarter and Full Year 2024	03-04
Stereotaxis Announces First Patients Successfully Treated Using Magic Ablation Catheter	01-08
Stereotaxis, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-09
Stereotaxis Says First US Arrhythmia Patients Treated with Robotic Navigation and Abbott's Cardiac Mapping System	23-10-31
Stereotaxis Launches and Successfully Completes the First Procedures Using the Advanced Genesis Robotic Magnetic Navigation System	23-08-30
Stereotaxis, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-10
Stereotaxis, Inc. Reiterates Revenue Guidance for the Year 2023	23-08-10
Stereotaxis' Robotic Technology Combined With Abbott's Cardiac Mapping System Treats Arrhythmia Patients	23-07-18
Stereotaxis to Initiate First-In-Human Trial to Support CE Mark Application of Magic Catheter	23-06-15
Stereotaxis Says First Arrhythmia Patients Treated With Genesis Robotic System at Chicago Hospital	23-05-23
Stereotaxis, Inc. Announces the First Treatment of Patients with Newly Launched Genesis Robotic Magnetic Navigation System At Advocate Christ Medical Center in Chicago, Illinois	23-05-23
Stereotaxis Files $100 Million Mixed Shelf	23-05-22
Top Midday Gainers	23-05-19
STEREOTAXIS INC SHARES UP 33.3% AFTER PARTNERSHIP WITH ABBOTT ON…	23-05-19
Stereotaxis, Inc. Reiterates Revenue Guidance for the Year 2023	23-05-09
Stereotaxis, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-09
Stereotaxis Announces Opening of A New Robotic Electrophysiology Program At Broward Health Medical Center in Fort Lauderdale, Florida	23-03-20
Stereotaxis, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-03

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Stereotaxis Inc Nasdaq

Equities

US85916J4094

Other languages

Filters